Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer

被引：0
|
作者：
Demosthenes Makris
Arnaud Scherpereel
Marie Christine Copin
Guillaume Colin
Luc Brun
Jean Jacques Lafitte
Charles Hugo Marquette
机构：
[1] CHRU of Lille,Pulmonary and Thoracic Oncology Department
[2] INSERM Unit 774,Pathology Department
[3] Institut Pasteur of Lille,Clinique des Maladies Respiratoires
[4] CHRU of Lille,undefined
[5] Hôpital Albert Calmette,undefined
[6] CHRU de Lille,undefined
来源：
BMC Cancer | / 7卷
关键词：
Docetaxel; Gemcitabine; Human Epidermal Growth Factor Receptor; Erlotinib; Interstitial Lung Disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer
    Makris, Demosthenes
    Scherpereel, Arnaud
    Copin, Marie Christine
    Colin, Guillaume
    Brun, Luc
    Lafitte, Jean Jacques
    Marquette, Charles Hugo
    BMC CANCER, 2007, 7 (1)
  • [2] Fatal interstitial lung disease associated with gemcitabine and erlotinib therapy for lung cancer
    Nasrallah, Haitam
    Bar-Sela, Gil
    Haim, Nissim
    MEDICAL ONCOLOGY, 2012, 29 (01) : 212 - 214
  • [3] Fatal interstitial lung disease associated with gemcitabine and erlotinib therapy for lung cancer
    Haitam Nasrallah
    Gil Bar-Sela
    Nissim Haim
    Medical Oncology, 2012, 29 : 212 - 214
  • [4] Fatal Asymmetric Interstitial Lung Disease after Erlotinib for Lung Cancer
    Ren, Shaohua
    Li, Yuan
    Li, Weiwen
    Zhao, Zhongwei
    Jin, Chunxian
    Zhang, Dengke
    RESPIRATION, 2012, 84 (05) : 431 - 435
  • [5] INTERSTITIAL LUNG DISEASE ASSOCIATED WITH ERLOTINIB/GEMCITABINE THERAPY IN PATIENTS WITH PANCREATIC CANCER
    Tanaka, Shigeru
    Shimokata, Tomoya
    Tsukuura, Hiroaki
    Maeda, Osamu
    Mitsuma, Ayako
    Ohno, Eizaburo
    Kawashima, Hiroki
    Hirooka, Yoshiki
    Goto, Hidemi
    Ando, Yuichi
    ANNALS OF ONCOLOGY, 2014, 25
  • [6] Fatal interstitial lung disease after erlotinib for non-small cell lung cancer
    Lind, Joline S. W.
    Smit, Egbert F.
    Grunberg, Katrien
    Senan, Suresh
    Lagerwaard, Frank. J.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (09) : 1050 - 1053
  • [7] Fatal interstitial lung disease associated with icotinib
    Zhang, Jiexia
    Zhan, Yangqing
    Ouyang, Ming
    Qin, Yinyin
    Zhou, Chengzhi
    Chen, Rongchang
    JOURNAL OF THORACIC DISEASE, 2014, 6 (12) : E267 - E271
  • [8] Fatal interstitial lung disease after erlotinib administration in a patient with radiation fibrosis
    Um, Soo-Jung
    Lee, Soo-Keol
    Yang, Doo Kyung
    Son, Choonhee
    Roh, Mee Sook
    Kim, Ki Nam
    Lee, Ki-Nam
    Choi, Pil Jo
    CLINICAL RESPIRATORY JOURNAL, 2009, 3 (03): : 181 - 184
  • [9] Erlotinib/OsimertinibRecurrent interstitial lung disease
    Reactions Weekly, 2023, 1985 (1) : 219 - 219
  • [10] Fatal interstitial lung disease associated with high erlotinib and metabolite levels. A case report and a review of the literature
    ter Heine, R.
    van den Bosch, R. T. A.
    Schaefer-Prokop, C. M.
    Lankheet, N. A. G.
    Beijnen, J. H.
    Staaks, G. H. A.
    van der Westerlaken, M. M.
    Malingre, M. M.
    van den Brand, J. J. G.
    LUNG CANCER, 2012, 75 (03) : 391 - 397
12345